Lv1
60 积分 2021-02-23 加入
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial
5个月前
已完结
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease
5个月前
已完结
Renal protective effect and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease and type 2 diabetes mellitus: a network meta-analysis and systematic review
5个月前
已完结
Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
5个月前
已完结
Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)
5个月前
已完结
10.1111/dom.12460
5个月前
已完结
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
5个月前
已完结
Role of artificial intelligence in pharmacy practice: A narrative review
6个月前
已完结
皖公网安备34019202002308
